You have 9 free searches left this month | to do more

trilaciclib

Trilaciclib is a drug used to treat Small Cell Lung Cancer, Breast Cancer, Chemotherapeutic Toxicity, and other conditions. Trilaciclib is being actively studied in 9 studies and prior, has been studied in 1.

Top SponsorsTop SitesTop Investigators
G1 Therapeutics, Inc.Millennium Oncology
Jiangsu Simcere Pharmaceutical Co., Ltd.Virginia Oncology Associates
Gibbs Cancer Center
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
G
Approved for marketing
  • Myelosuppression Adult
  • +2 more
  • Trilaciclib
  • (no location specified)
2021-03-17
Mar 17, 2021
G
Recruiting
  • Urothelial Carcinoma
  • +4 more
  • Trilaciclib
  • +4 more
  • Whittier, California
  • +11 more
2021-10-05
Oct 5, 2021
G
Recruiting
  • Metastatic Non-Small Cell Lung Cancer
  • +2 more
  • Trilaciclib
  • +2 more
  • Phoenix, Arizona
  • +11 more
2021-09-20
Sep 20, 2021
G
Recruiting
  • TNBC - Triple-Negative Breast Cancer
  • Breast Cancer
  • Trilaciclib
  • +3 more
  • Birmingham, Alabama
  • +28 more
2021-10-13
Oct 13, 2021
G
Active, not recruiting
  • Small Cell Lung Cancer
  • Trilaciclib
  • +4 more
  • Beverly Hills, California
  • +43 more
2021-01-25
Jan 25, 2021
G
Active, not recruiting
  • Triple-Negative Breast Neoplasms
  • +3 more
  • Trilaciclib
  • +2 more
  • Tucson, Arizona
  • +53 more
2021-01-25
Jan 25, 2021
G
Active, not recruiting
  • Small Cell Lung Cancer
  • Trilaciclib
  • +2 more
  • Hot Springs, Arkansas
  • +49 more
2021-01-25
Jan 25, 2021
G
Recruiting
  • Colorectal Cancer Metastatic
  • +2 more
  • Trilaciclib
  • Placebo
  • Tucson, Arizona
  • +121 more
2021-09-15
Sep 15, 2021